1. INTRODUCTION {#sec1-1}
===============

Chronic renal failure (CRF) represent an important public health problem due to the strikingly high incidence and prevalence of this disease in the world ([@ref1], [@ref2]). Together with an increased incidence of the disease also has increased the number of other pathological conditions caused by CRF including renal failure, cardiovascular diseases and lethal outcome. For a long time the evaluation and treatment of renal diseases were focused on the diagnosis and treatment of each identified renal disease. Studies conducted in the past 10 years have shown that adverse CRF outcomes can prevent or delay by reduction of risk factors and the inclusion of adequate therapy even in the early stages of renal failure, not taking into account the causes that led to the CRF ([@ref3]). Results of researches and epidemiological studies suggest that increased body mass index is an independent risk factor when it comes to the occurrence and development of CRF ([@ref4]).

2. MATERIAL AND METHODS {#sec1-2}
=======================

One-year prospective clinical study (January 2011 to January 2012) conducted at the Clinical Center University of Sarajevo, Bosnia and Herzegovina, included 150 patients who were in various stages of chronic renal failure (stage I to IV). Each study group consisted of 30 patients, also with the control group of 30 healthy individuals. The study included all the information about age, complete laboratory analysis of patients with chronic renal failure and 30 individuals who does not have chronic renal failure. Patients who are excluded from the study were as follows: patients in the terminal stage of chronic renal insufficiency (stage V), patients with kidney transplant, patients with unstable renal function, patients with newly diagnosed diabetes, polycystic kidney disease, hydronephrosis, renal anomalies, renal tumors and accompanying decompensating disease.

In the study, we used the medical records of patients that contained the necessary clinical, laboratory and demographic data. At admission to each patient were taken demographic and anthropometric data (gender, age, height and weight) as well as possible comorbidity. Estimate of creatinine clearance was performed using Cockroft-Goult formula ([@ref5]). BMI is calculated using the formula: BMI=weight/height[@ref2] (kg/m^2^). According to the classification of nutritional status based on BMI, proposed by the World Health Organization (WHO), the subjects of the study were classified into different groups of the nutritional status ([@ref6]). The classification of patients according to stages of chronic renal insufficiency was performed in accordance with the criteria of Kidney Disease Outcomes Quality Initiative (K/DOQI) ([@ref1]).

Results of the study were analyzed using descriptive statistics which includes determining the mean, standard deviation and standard error. Pearson correlation was used to assess the correlation. Statistically significant was considered values of the test with p\<0.05.

3. RESULTS {#sec1-3}
==========

Of the total number of subjects (N=150) 71 were male and 79 female. The mean age of patients was 55.43 years, and the age structure of the subjects of the study are shown in [Table 1](#T1){ref-type="table"}.

###### 

Mean age of patients involved in the study by each group. U=9.616; DF = 4; p=0.0001
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The mean BMI of the respondents by nutritional status according to the WHO classification is shown in [Table 2](#T2){ref-type="table"}.

###### 

BMI of the patients
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Analysis of the average values of BMI through various stages of CRF showed a slight decrease in this parameter in accordance with the higher stages of renal disease ([Table 3](#T3){ref-type="table"}). Statistical analysis shows that there is a statistically significant difference in mean BMI values between the study groups (p\<0.05).

###### 

Mean BMI of patients in each group U=2.761; DF = 4; p = 0.030
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Analysis of the relationship between the nutritional status according to BMI and CRF stage is shown in [Table 4](#T4){ref-type="table"}

###### 

Relationship between BMI and stage of CRF. x2 =11.398; DF = 12; p=0.249. Rho=-0.166; p=0.070
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Statistical analysis of the body mass index--BMI in relation to the stage of renal failure indicates that there is no statistically significant difference or correlation (p\>0.05).

4. DISCUSSION {#sec1-4}
=============

When it comes to gender representation of patients in the study there is evident predominance of women corresponding data from the literature ([@ref7]). The obtained results showed that age of our subjects clearly indicates a link between older age of patients and progression of chronic renal failure, which also corresponds to the literature data, according to which the prevalence of chronic renal failure varies significantly with age and was higher in the elderly ([@ref8]).

The mean BMI of our patients was 27.1547 kg/m^2^, values range from 17.21 to 38.10 kg/m^2^. In our study, we concluded that the BMI values decrease with the development of chronic renal insufficiency. Review of the available literature revealed that many authors suggest that there is a clear correlation between obesity and the development of chronic renal failure and that obesity is a risk factor for development of chronic renal failure, which can directly or indirectly lead to renal failure ([@ref9]). In our study, we did not demonstrated a correlation between increased BMI and the occurrence of renal failure nor have we found significant correlation between increased BMI and the progression of chronic renal failure, which corresponds to the study by Brown et al ([@ref10]). Results obtained in our study may be explained by the fact that obesity is commonly associated with diabetes, the most common cause of chronic renal failure, since our study did not include patients with diabetes.

5. CONCLUSION {#sec1-5}
=============

We did not demonstrate significant correlation between increased body mass index and the occurrence or development of renal failure in patients who do not have diabetes.
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